Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STERAL: Switching Efavirenz to Raltegravir for Liver Steatosis
NCT01900015Phase 4Completed
- Start
- Feb 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV). Started Feb 2014; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01900015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900015.